These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23712696)

  • 1. Specifically monitoring butyrylcholinesterase by supramolecular tandem assay.
    Guo DS; Yang J; Liu Y
    Chemistry; 2013 Jul; 19(27):8755-9. PubMed ID: 23712696
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers.
    Hamulakova S; Imrich J; Janovec L; Kristian P; Danihel I; Holas O; Pohanka M; Böhm S; Kozurkova M; Kuca K
    Int J Biol Macromol; 2014 Sep; 70():435-9. PubMed ID: 25036600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
    Elsinghorst PW; Tanarro CM; Gütschow M
    J Med Chem; 2006 Dec; 49(25):7540-4. PubMed ID: 17149883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Makhaeva GF; Kovaleva NV; Lushchekina SV; Rudakova EV; Boltneva NP; Proshin AN; Lednev BV; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2018 Nov; 483(1):369-373. PubMed ID: 30607741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved immobilized enzyme reactor-mass spectrometry-based label free assay for butyrylcholinesterase ligand screening.
    Vilela AFL; Seidl C; Lima JM; Cardoso CL
    Anal Biochem; 2018 May; 549():53-57. PubMed ID: 29550345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.
    Savini L; Gaeta A; Fattorusso C; Catalanotti B; Campiani G; Chiasserini L; Pellerano C; Novellino E; McKissic D; Saxena A
    J Med Chem; 2003 Jan; 46(1):1-4. PubMed ID: 12502352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
    Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
    J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescent probe for butyrylcholinesterase activity in human serum based on a fluorophore with specific binding affinity for human serum albumin.
    Yoo S; Han MS
    Chem Commun (Camb); 2019 Dec; 55(97):14574-14577. PubMed ID: 31663530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NO-donating tacrine derivatives as potential butyrylcholinesterase inhibitors with vasorelaxation activity.
    Chen Y; Sun J; Huang Z; Liao H; Peng S; Lehmann J; Zhang Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3162-5. PubMed ID: 23639542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors.
    Szymański P; Markowicz M; Mikiciuk-Olasik E
    Bioorg Chem; 2011 Aug; 39(4):138-42. PubMed ID: 21621811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel conjugates of tacrine with 1,2,4,-thiadiazole as highly effective cholinesterase inhibitors, blockers of NMDA receptors, and antioxidants.
    Makhaeva GF; Grigoriev VV; Proshin AN; Kovaleva NV; Rudakova EV; Boltneva NP; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2017 Nov; 477(1):405-409. PubMed ID: 29297118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
    Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
    Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,4-Dinitrobenzenesulfonyl fluoresceins as fluorescent alternatives to Ellman's reagent in thiol-quantification enzyme assays.
    Maeda H; Matsuno H; Ushida M; Katayama K; Saeki K; Itoh N
    Angew Chem Int Ed Engl; 2005 May; 44(19):2922-5. PubMed ID: 15818626
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
    Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.
    Decker M
    J Med Chem; 2006 Sep; 49(18):5411-3. PubMed ID: 16942014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
    Camps P; Formosa X; Muñoz-Torrero D; Petrignet J; Badia A; Clos MV
    J Med Chem; 2005 Mar; 48(6):1701-4. PubMed ID: 15771413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
    Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
    J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.